Aytu BioPharma, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | — | $7.1M | $11.0M |
| FY2020 | $0 | $95.0M | $48.1M |
| FY2021 | $180.0K | $137.6M | $49.6M |
| FY2022 | $15.0M | $44.3M | $19.4M |
| FY2023 | $14.7M | $39.4M | $23.0M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | — | $7.1M | $11.0M |
| FY2020 | $0 | $95.0M | $48.1M |
| FY2021 | $180.0K | $137.6M | $49.6M |
| FY2022 | $15.0M | $44.3M | $19.4M |
| FY2023 | $14.7M | $39.4M | $23.0M |